The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
More ‘Malignant’ Than Cancer? Five-Year Survival Following a First Admission for Heart Failure
Open accessAbstract
Background: The prognostic impact of heart failure relative to that of ‘high-profile’ disease states such as cancer, within the whole population, is unknown. Methods: All patients with a first admission to any Scottish hospital in 1991 for heart failure, myocardial infarction or the four most common types of cancer specific to men and women were identified. Five-year survival rates and associated loss of expected life-years were then compared. Results: In 1991, 16224 men had an initial hospitalisation for heart failure (n - 3241), myocardial infarction (n - 6932) or cancer of the lung, large bowel, prostate or bladder (n - 6051). Similarly, 14842 women were admitted for heart failure (n - 3606), myocardial infarction (n - 4916), or cancer of the breast, lung, large bowel or ovary (n - 6320). With the exception of lung cancer, heart failure was associated with the poorest 5-year survival rate (approximately 25% for both sexes). On an adjusted basis, heart failure was associated with worse long-term survival than bowel cancer in men (adjusted odds ratio, 0.89; 95% CI, 0.82–0.97; P < 0.01) and breast cancer in women (odds ratio, 0.59; 95% CI, 0.55–0.64; P < 0.001). The overall population rate of expected life-years lost due to heart failure in men was 6.7 years/1000 and for women 5.1 years/1000. Conclusion: With the notable exception of lung cancer, heart failure is as ‘malignant’ as many common types of cancer and is associated with a comparable number of expected life-years lost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Stewart, A. L. (1989) · JAMA · doi:10.1001/jama.262.7.907 · Cited by 2,085
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Ho, K. K., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D. (1993) · Circulation · doi:10.1161/01.cir.88.1.107 · Cited by 1,869
Stewart, A. L. (1989) · JAMA · doi:10.1001/jama.1989.03430070055030 · Cited by 1,735
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction
Vasan, R. S., Larson, S., Benjamin, E. J., Evans, J. C., Reiss, C. K., & Levy, D. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00118-7 · Cited by 1,331
Deprivation and Health in Scotland
Tunstall-Pedoe, H. (1993) · Postgraduate Medical Journal · doi:10.1136/pgmj.69.814.665-a · Cited by 1,167
Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death.
Schneider, B. A. (1953) · The Quarterly Review of Biology · doi:10.1086/399926 · Cited by 991
Is screening for breast cancer with mammography justifiable?
Gøtzsche, P. C., & Olsen, O. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06065-1 · Cited by 853
Prevalence and mortality rate of congestive heart failure in the United States
Schocken, D. D., Arrieta, M. I., Leaverton, P. E., & Ross, E. A. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90094-4 · Cited by 817
Stewart, S., Marley, J. E., & Horowitz, J. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03428-5 · Cited by 635
Self-citation
Cited by
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Self-citationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
Self-citationEpidemiology and risk profile of heart failure
Bui, A. L., Horwich, T. B., & Fonarow, G. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.165 · Cited by 2,077
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01236-6 · Cited by 1,562
Self-citationClark, R. A., Inglis, S. C., McAlister, F. A., Cleland, J. G. F., & Stewart, S. (2007) · BMJ · doi:10.1136/bmj.39156.536968.55 · Cited by 672
Self-citation
Metadata
- Authors
- Stewart, S., MacIntyre, K., Hole, D. J., Capewell, S., & McMurray, J. J. V.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-06-01
- Volume
- 3
- Issue
- 3
- Pages
- 315-322
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W1964714332
- Cited by
- 1,050
- References
- 31
- FWCI
- 24.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: More ‘Malignant’ Than Cancer? Five-Year Survival Following a First Admission for Heart Failure. https://app.cochat.ai/papers/10.1016/s1388-9842(00)00141-0
- The paper
- Stewart, S., MacIntyre, K., Hole, D. J., Capewell, S., & McMurray, J. J. V. (2001). More ‘Malignant’ Than Cancer? Five-Year Survival Following a First Admission for Heart Failure. European Journal of Heart Failure. https://doi.org/10.1016/s1388-9842(00)00141-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
